Sakshi Sharma

Department of Community Medicine, Datta Meghe Institute of Medical Sciences (Deemed University), India


  • Research   
    Effect of Dexamethasone in Hospitalized Covid-19 Patients-Preliminary Report
    Author(s): Sakshi Sharma, Lokesh Vaishnav, Abhishek Joshi* and Ashok Mendhale

    Introduction: Covid19 is a viral disease caused due to Severe Acute Respiratory Syndrome Coronavirus 2 . It causes mild to moderate lung damage.. Most of the patients are either presenting with no symptoms or with mild symptoms but there are some patients who presented with severe lung damage and needed hospitalization. Severe covid 19 is marked by inflammatory organ injury. The use of Corticosteroids helped in suppressing inflammation and reduced chances of landing in respiratory failure. Method: The trial referred to as RECOVERY (Randomized Evaluation of COVID-19 Therapy) which is controlled, randomized, open trial was performed in which 6mg dexamethasone was randomly given once daily to the patients for ten days and was then compared to the patients given basic care only. The 28-day mortality was reduced as a result. Result: 4321 patients were randomly selected for usual care treat.. Read More»

    Abstract HTML PDF